Search research articles
Contact Us
Filters
Showing results (151-160 of 1,989) with videos related to
Page
of 199
Sort By:
Journal of Parkinson'S Disease
|
November 25, 2025
Clinical trial highlights: Dopamine cell-replacement therapies
Saeed Kayhanian, Roger A Barker
Brain : a Journal of Neurology
|
January 27, 2024
The basal forebrain cholinergic system as target for cell replacement therapy in Parkinson's disease
Anders Björklund, Roger A Barker
Clinical and Translational Medicine
|
June 26, 2024
Brain cholesterol therapy for Huntington's disease - Does it make sense?
Elena Cattaneo, Roger A Barker
Journal of Experimental Psychology. Learning, Memory, and Cognition
|
May 25, 2006
Hidden covariation detection produces faster, not slower, social judgments
Lynne A Barker, Jackie Andrade
Expert Opinion on Biological Therapy
|
April 19, 2005
Cell therapies for neurological disease--from bench to clinic to bench
Timothy Harrower, Roger A Barker
Neuron
|
June 15, 2005
Getting RIP'd Stunts Your Growth
Claire Ceni, Philip A Barker
Archives of Microbiology
|
December 1, 1985
p-Cresol formation by cell-free extracts of Clostridium difficile
L D'Ari, H A Barker
Biochemical and Biophysical Research Communications
|
February 13, 2001
TTIP is a novel protein that interacts with the truncated T1 TrkB neurotrophin receptor
D Kryl, P A Barker
Journal of Neural Transmission (Vienna, Austria : 1996)
|
November 3, 2014
On the transmethylation hypothesis: stress, N,N-dimethyltryptamine, and positive symptoms of psychosis
Dionysios Grammenos, Steven A Barker
Nature Reviews. Neurology
|
April 6, 2019
Parkinson disease and growth factors - is GDNF good enough?
Agnete Kirkeby, Roger A Barker
Page
of 199
Search research articles
Search
Showing results (151-160 of 1,989) with videos related to
Sort By:
Page
of 199
Journal of Parkinson'S Disease
|
November 25, 2025
Clinical trial highlights: Dopamine cell-replacement therapies
Saeed Kayhanian, Roger A Barker
Brain : a Journal of Neurology
|
January 27, 2024
The basal forebrain cholinergic system as target for cell replacement therapy in Parkinson's disease
Anders Björklund, Roger A Barker
Clinical and Translational Medicine
|
June 26, 2024
Brain cholesterol therapy for Huntington's disease - Does it make sense?
Elena Cattaneo, Roger A Barker
Journal of Experimental Psychology. Learning, Memory, and Cognition
|
May 25, 2006
Hidden covariation detection produces faster, not slower, social judgments
Lynne A Barker, Jackie Andrade
Expert Opinion on Biological Therapy
|
April 19, 2005
Cell therapies for neurological disease--from bench to clinic to bench
Timothy Harrower, Roger A Barker
Neuron
|
June 15, 2005
Getting RIP'd Stunts Your Growth
Claire Ceni, Philip A Barker
Archives of Microbiology
|
December 1, 1985
p-Cresol formation by cell-free extracts of Clostridium difficile
L D'Ari, H A Barker
Biochemical and Biophysical Research Communications
|
February 13, 2001
TTIP is a novel protein that interacts with the truncated T1 TrkB neurotrophin receptor
D Kryl, P A Barker
Journal of Neural Transmission (Vienna, Austria : 1996)
|
November 3, 2014
On the transmethylation hypothesis: stress, N,N-dimethyltryptamine, and positive symptoms of psychosis
Dionysios Grammenos, Steven A Barker
Nature Reviews. Neurology
|
April 6, 2019
Parkinson disease and growth factors - is GDNF good enough?
Agnete Kirkeby, Roger A Barker
Page
of 199